1. Home
  2. AZTR vs RAYA Comparison

AZTR vs RAYA Comparison

Compare AZTR & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azitra Inc

AZTR

Azitra Inc

HOLD

Current Price

$0.23

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$4.01

Market Cap

3.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTR
RAYA
Founded
2014
2019
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.1M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
AZTR
RAYA
Price
$0.23
$4.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
453.5K
35.0K
Earning Date
05-08-2026
04-17-2026
Dividend Yield
N/A
N/A
EPS Growth
5.06
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$20.95
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$0.03
52 Week High
$1.40
$10.14

Technical Indicators

Market Signals
Indicator
AZTR
RAYA
Relative Strength Index (RSI) 51.63 58.09
Support Level $0.21 $3.57
Resistance Level $0.23 $4.17
Average True Range (ATR) 0.02 0.29
MACD 0.00 -0.02
Stochastic Oscillator 74.80 44.59

Price Performance

Historical Comparison
AZTR
RAYA

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc is engaged in the manufacturing, research and development (R&D), and wholesale and retail of power solution products. The group focuses on manufacturing new energy storage and inverter devices. Its product portfolio includes sine wave and off-grid inverters, inverters and gasoline generators, battery and smart chargers, and custom-designed products. The products are used principally in agricultural and industrial vehicles, recreational vehicles (RVs), electrical appliances, and outdoor living products. The company generates the majority of its revenue from Inverters. The company generates revenue from five main markets, which are China, Poland, Mexico, the U.K., and Portugal. It derives maximum revenue from China.

Share on Social Networks: